The beginning of the new week is marked by investors' hopes and concerns regarding important geopolitical and macroeconomic factors. The Trump-Putin meeting in Alaska took place without commitments or declarations regarding peace, which is reflected in market disappointment.
According to a Deutsche Bank report, investor sentiment has fallen to its lowest level in 3 months.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appApollo Sløk also warns about the deteriorating macro environment. The decline in maritime trade flows signals a weakening consumer. A Scandinavian private fund also points out that capital allocation in AI companies already exceeds the extremes from the Dot-Com bubble period.
Source: Appolo Sløk.
Source: Bloomberg Finance LP
After the unproductive meeting in Alaska, another uncertainty that the market is waiting to be resolved is the FED's stance on future policy. The market is searching for direction, but still cannot find it, as the session opens at Friday's closing level.US500 (D1)
The main index of the Wall Street stock exchange is currently at the upper limit of a narrowing consolidation channel, within an upward trend. The price is well above the averages, yet the RSI indicators do not yet suggest overbought conditions. The market is searching for a reason to continue rising, but if it doesn't find one, the fall could be painful. In such a case, the initial support levels are 6360, followed by 6250, where the recent lows and the EMA50 average are located. Additional support may come from the EMA100 and EMA200 averages, with the latter also positioned at the lows from 2 months ago, making it a very important level in the event of potential declines.
Company's News:
UnitedHealth Group (UNH.US) - The star of the session is currently the controversial company providing services in the health insurance industry. The company has had a very tough year, but its bad streak may reverse following the announcement on Friday of large purchases of shares and options by Warren Buffett and Michael Burry. On Friday, the company closed the session with a growth gap of over 10%. On Monday, UnitedHealth is rising another 2% at the opening. Time will tell if the change in sentiment is lasting.
Source: Xstation
Palo Alto (PANW.US) - At the end of Monday's session, one of the leaders in the cybersecurity industry is set to release its results for the first half of 2025. Expectations are for revenues of $2.5 billion and EPS of 0.85, marking another growth milestone for the company.
Novo Nordisk (NVO.US) - The pharmaceutical company, known for its breakthrough obesity drug Ozempic, is recovering some of its recent losses on a wave of optimism related to a new product that has received FDA approval. The drug, "Wegovy," aids in the treatment of liver diseases.
US Tax Credit - New rules for granting tax credits for renewable energy infrastructure in the USA are supporting valuations of companies in this sector. Among these companies is Vestas, which is up 15%.
Soho House (SHCO.US) - The American hospitality and restaurant company is set to be acquired by a private investment fund. The investment group is willing to pay $9 per share, representing an 18% premium over the current market valuation.
Dayforce (DAY.US) - The company providing software solutions for businesses is up 13% on news of being selected as a supplier by Thoma Bravo.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
